Table 4.
Cotinine substitution concentrations
| Period | Patch and nicotine spray
|
Patch and placebo spray
|
|||||
|---|---|---|---|---|---|---|---|
| Users* | Mean | % of baseline cotinine† | Users* | Mean | % of baseline cotinine† | ||
| Baseline | 111 | 378 | 100 | 111 | 341 | 100 | |
| 1 day | 94 | 227 | 60.1 | 90 | 170 | 49.9 | |
| 15 days | 61 | 171 | 45.2 | 56 | 128 | 37.5 | |
| 43 days | 31 | 192 | 50.8 | 38 | 136 | 39.9 | |
| 3 months | 16 | 191 | 50.5 | 27 | 88 | 25.8 | |
| 6 months | 8 | 226 | 59.8 | 0 | 0 | 0 | |
| 12 months | 4 | 495 | 131 | 0 | 0 | 0 | |
Those abstinent in respective treatment groups and using prescribed nicotine as either patch with nicotine nasal spray or patch only. At baseline, users refers to smokers.
Percentages at each follow up derived from mean cotinine concentration at baseline.